Quantitative analysis of crystalline pharmaceuticals in powders and tablets by a pattern-fitting procedure using X-ray powder diffraction data.
A pattern-fitting procedure for quantitative analysis of crystalline pharmaceuticals in solid dosage forms using X-ray powder diffraction data is described. This method is based on a procedure for pattern-fitting in crystal structure refinement, and observed X-ray scattering intensities were fitted to analytical expressions including some fitting parameters, i.e. scale factor, peak positions, peak widths and degree of preferred orientation of the crystallites. All fitting parameters were optimized by the non-linear least-squares procedure. Then the weight fraction of each component was determined from the optimized scale factors. In the present study, well-crystallized binary systems, zinc oxide-zinc sulfide (ZnO-ZnS) and salicylic acid-benzoic acid (SA-BA), were used as the samples. In analysis of the ZnO-ZnS system, the weight fraction of ZnO or ZnS could be determined quantitatively in the range of 5-95% in the case of both powders and tablets. In analysis of the SA-BA systems, the weight fraction of SA or BA could be determined quantitatively in the range of 20-80% in the case of both powders and tablets. Quantitative analysis applying this pattern-fitting procedure showed better reproducibility than other X-ray methods based on the linear or integral intensities of particular diffraction peaks. Analysis using this pattern-fitting procedure also has the advantage that the preferred orientation of the crystallites in solid dosage forms can be also determined in the course of quantitative analysis.
Yamamura
S
S
School of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi, 274-8510, Chiba, Japan. yamamura@phar.toho-u.ac.jp
Momose
Y
Y
D019817:Benzoic Acid / Q000032:analysis; D003460:Crystallization; D011208:Powders; D020156:Salicylic Acid / Q000032:analysis; D013440:Sulfides / Q000032:analysis; D013607:Tablets; D014961:X-Ray Diffraction; D017967:Zinc Compounds / Q000032:analysis; D015034:Zinc Oxide / Q000032:analysis
D011208:Powders; D013440:Sulfides; D013607:Tablets; D017967:Zinc Compounds; D019817:Benzoic Acid; C031238:zinc sulfide; D020156:Salicylic Acid; D015034:Zinc Oxide